title: Cases of acquired C1 inhibitor deficiency treated with rituximab.
authors.affiliation: Division of Allergy, Immunology, and Rheumatology, University of California - San Diego, San Diego, Calif. Electronic address: ashmi.doshi@gmail.com.
authors.forename: Ashmi
authors.initials: A
authors.lastname: Doshi
authors.affiliation: Department of Allergy, Kaiser Permanente Medical Center, San Diego, Calif.
authors.forename: Kevin
authors.initials: K
authors.lastname: Tse
authors.affiliation: Division of Allergy, Immunology, and Rheumatology, University of California - San Diego, San Diego, Calif.
authors.forename: Marc
authors.initials: M
authors.lastname: Riedl
authors.affiliation: Division of Allergy, Immunology, and Rheumatology, University of California - San Diego, San Diego, Calif.
authors.forename: Bruce
authors.initials: B
authors.lastname: Zuraw
authors.affiliation: Division of Allergy, Immunology, and Rheumatology, University of California - San Diego, San Diego, Calif.
authors.forename: Sandra
authors.initials: S
authors.lastname: Christiansen
mesh_terms: D054179:Angioedemas, Hereditary / Q000188:drug therapy* / Q000209:etiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001920:Bradykinin / Q000031:analogs & derivatives / Q000627:therapeutic use; D050718:Complement C1 Inhibitor Protein; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D050718:Complement C1 Inhibitor Protein; D007155:Immunologic Factors; D000069283:Rituximab; C065679:icatibant; D001920:Bradykinin